I-SPY2 Trial Highlights Treatment for Rare Breast Cancer… : Oncology Times
An abstract is unavailable.
Related Articles
NICE Advocates Reimbursement for Avapritinib in Aggressive Systemic Mastocytosis, Other Hematologic Malignancies
NICE issued a final guidance recommending reimbursement of avapritinib monotherapy in adult patients with ASM, SM-AHN, or mast cell leukemia.
MI Cancer Seek Receives FDA Approval as Companion Diagnostic for Targeted Therapy Across Tumor Types
MI Cancer Seek has been granted FDA approval as a companion diagnostic for patients with cancer who may benefit from targeted therapy.
At End of Life, Patients With Neurologic Diseases Often… : Neurology Today
An abstract is unavailable.
Frontline Vibostolimab/Pembrolizumab Plus Chemo Meets Futility Threshold in ES-SCLC
Co-formulated vibostolimab and pembrolizumab plus chemotherapy failed to improve OS in the first line vs atezolizumab plus chemotherapy in ES-SCLC.
Obinutuzumab and Liso-Cel Revisions to CLL/SLL NCCN Guidelines Mark Most Notable Changes of 2024
Matthew Cortese, MD, MPH, details 2024/2025 updates to the NCCN guidelines for CLL/SLL and treatments to look forward to in the future.
FDA Grants Orphan Drug Designation to LBL-034 for Multiple Myeloma
The FDA has granted orphan drug designation to LBL-034 for the treatment of patients with multiple myeloma.
NICHE-2: nivolumab and ipilimumab in non-metastatic MSI-high colon cancer
John Strickler, MD, Duke Cancer Institute, Durham, NC, gives an overview of the NICHE-2 trial (NCT03026140), which assessed immunotherapy for non-metastatic MSI-high colon cancer. Traditionally…
Clive Peedell (@drpeedell.bsky.social)
Consultant Clinical Oncologist NHS advocate and campaigner Politically centre left Wealth inequality creates health inequality
ASH Visitor Training Program
The Visitor Training Program (VTP) is intended to help build hematology capacity in developing countries by providing funding for hematologists or hematology-related health care professionals…
ASH Visitor Training Program
The Visitor Training Program (VTP) is intended to help build hematology capacity in developing countries by providing funding for hematologists or hematology-related health care professionals…